Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 71,028 | 64,485 | 70,505 | 84,687 | 67,853 |
| Cost of Goods | 44,537 | 42,381 | 45,276 | 44,843 | 47,281 |
| Gross Profit | 26,491 | 22,104 | 25,229 | 39,844 | 20,572 |
| Operating Expenses | 45,934 | 44,283 | 176,626 | 40,473 | 40,651 |
| Operating Income | -18,906 | -21,798 | -151,121 | 214 | -19,798 |
| Interest Expense | 25 | -249 | 418 | 70 | 0 |
| Other Income | 7,717 | 7,376 | 6,343 | 6,716 | 5,098 |
| Pre-tax Income | -11,214 | -14,173 | -145,196 | 6,860 | -14,700 |
| Income Tax | -2,124 | -327 | -10,862 | 20,326 | -3,110 |
| Net Income Continuous | -9,090 | -13,846 | -134,334 | -13,466 | -11,590 |
| Minority Interests | -380 | -384 | -6,185 | -359 | -361 |
| Net Income | $-8,710 | $-13,462 | $-128,149 | $-13,107 | $-11,229 |
| EPS Basic Total Ops | -0.29 | -0.45 | -4.29 | -0.44 | -0.38 |
| EPS Basic Continuous Ops | -0.30 | -0.47 | -4.51 | -0.45 | -0.39 |
| EPS Diluted Total Ops | -0.29 | -0.45 | -4.29 | -0.44 | -0.38 |
| EPS Diluted Continuous Ops | -0.30 | -0.47 | -4.51 | -0.45 | -0.39 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.38 | -0.02 | N/A | N/A |
| EBITDA(a) | $-14,239 | $-16,319 | $-25,883 | $5,443 | $-14,200 |